
Finance & M&A
Tempus acquires Personalis in $1.5bn deal, deepening push into cancer genomics
The AI-diagnostics firm absorbs its oncology genomics partner three years after their initial collaboration — and sets up a direct contest with Foundation Medicine for NHS pathology contracts. Full deal terms, adviser detail and competitive landscape analysis in the intelligence database.